Advertisement

Topics

Eli Lilly Reports Positive Results From Phase 3b/4 Study Of Taltz

07:34 EDT 14 Jun 2019 | FinanzNachrichten

INDIANAPOLIS (dpa-AFX) - Eli Lilly and Company (LLY) said Taltz demonstrated effectiveness in improving the signs and symptoms of active psoriatic arthritis in a Phase 3b/4 SPIRIT-Head-to-Head stu...

Original Article: Eli Lilly Reports Positive Results From Phase 3b/4 Study Of Taltz

NEXT ARTICLE

More From BioPortfolio on "Eli Lilly Reports Positive Results From Phase 3b/4 Study Of Taltz"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...